Drugs / Acid Nicotinique
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00855257 | Jun 2007 → May 2009 | acute coronary syndrome | French Cardiology Society | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Acid Nicotinique | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00855257 ↗ |
| Known as | Niaspan | “the Acid Nicotinique (Niaspan®), only molecule currently marketed, ready to raise the plasmatic levels of HDL-c.” NCT00855257 ↗ |